Bruker Corporation to Present at Investor Conferences

Rhea-AI Summary

Bruker Corporation (NASDAQ: BRKR) announced that Executive Vice President and CFO Gerald Herman will present at two upcoming investor conferences. The first is the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference in New York City on March 2, 2023, at 9:30 a.m. ET. The second is the Cowen 43rd Annual Health Care Conference in Boston, MA, scheduled for March 6, 2023, at 2:10 p.m. ET. The presentations will be available via live webcasts on the Company’s Investor Relations website, with replays accessible for 90 days following the events.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:

Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference in New York City
Thursday, March 2, 2023, at 9:30 a.m. Eastern Time

Cowen 43^rd Annual Health Care Conference in Boston, MA
Monday, March 6, 2023, at 2:10 p.m. Eastern Time

Live audiovisual webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays of the presentations will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the events and will be available for 90 days following the presentations.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life-science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial research, semiconductor metrology and cleantech applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005988/en/

Justin Ward

Sr. Director, Investor Relations & Corporate Development

Bruker Corporation

T: +1 (978) 663–3660, ext. 1479

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

What conferences will Bruker Corporation participate in March 2023?

Bruker Corporation will participate in the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference on March 2, 2023, and the Cowen 43rd Annual Health Care Conference on March 6, 2023.

Who is presenting for Bruker Corporation at the investor conferences?

Gerald Herman, Executive Vice President and CFO, will present for Bruker Corporation at the investor conferences.

Where can I watch the Bruker Corporation conference presentations?

Live webcasts of the presentations will be available on Bruker Corporation's Investor Relations website.

How long will the Bruker Corporation conference presentations be available online?

The replays of the presentations will be available for 90 days following the events.

What is the stock symbol for Bruker Corporation?

The stock symbol for Bruker Corporation is BRKR.